C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
12/2004
12/28/2004	US6835474 Red fluorescent dyes having high fluorescent strength and high color purity; high luminance; high efficacy by low voltage-driving; stability; durability; color conversion filter, pulp dyeing; photographic dye; sensitizers
12/23/2004	WO2004110453A1 Pyrimidine derivatives as cannabinoid receptor ligands
12/23/2004	WO2004074270A3 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
12/23/2004	WO2004071447A3 Substituted azole derivatives as therapeutic agents
12/23/2004	US20040260076 Isolation, purification and synthesis of procyanidin B2 and uses thereof
12/23/2004	US20040259887 Cannabinoid receptor ligands and uses thereof
12/23/2004	US20040259876 Bicyclic compound, production and use thereof
12/23/2004	CA2529068A1 Pyrimidine derivatives as cannabinoid receptor ligands
12/22/2004	EP1487825A1 Process to obtain dibenzylbutyrolactonic lignans; process to obtain synthetic derivatives from lignanes bearing anti-chagas chemoprophylactic and therapeutical activities
12/22/2004	EP1487813A1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
12/22/2004	EP1086076B1 Sulfonamide inhibitors of aspartyl protease
12/22/2004	CN1181087C Novel antibacterial compounds
12/21/2004	US6833372 A hormone inhibitors of gonadotropin releasing hormone, an antigonadotropins, new drug compound contains a furanyl 2-carboxylic acid -(2,4-dimethoxy-pyrimidin-5-yl)-amide groups
12/16/2004	WO2004087686A3 Benzopyran compounds useful for treating inflammatory conditions
12/16/2004	US20040254123 Using benzylidene ascorbate in mixture with carrier
12/16/2004	US20040252171 Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method
12/15/2004	EP1486526A1 Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method
12/15/2004	EP1485387A1 Carbamates as hiv protease inhibitors
12/15/2004	EP1485377A1 Pyranones useful as atm inhibitors
12/15/2004	EP1485358A1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
12/15/2004	EP1485167A1 1,2-dihydropyrazol-3-ones as cytokine mediators
12/14/2004	US6831096 Effective against both A and B forms of influenza; oral bioavailability
12/14/2004	US6831080 Cinnamide derivatives as KCNQ potassium channel modulators
12/09/2004	WO2004106317A1 Benzofuran compound and medicinal composition containing the same
12/09/2004	WO2004106302A1 Novel substituted 3-sulfur indoles
12/09/2004	WO2004075863A3 Cxcr3 antagonists
12/08/2004	EP1119548B1 3-(3-chloro-4-hydroxyphenylamino)-4-(2-nitrophenyl)-1h-pyrrole-2,5-dione as glycogen synthase kinase-3 inhibitor (gsk-3)
12/08/2004	CN1553895A Taxol enhancer compounds
12/08/2004	CN1552708A Three compounds from traditional Chinese medicine
12/08/2004	CN1178912C Small molecule inhibitors of rotamase enzyme activity
12/07/2004	US6828446 Aromatic thioether liver X-receptor modulators
12/07/2004	US6828444 Process for use in 11-oxa prostaglandin synthesis
12/07/2004	US6828348 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same
12/07/2004	CA2352332C Hygromycin a derivatives
12/02/2004	WO2004072031A3 Phenylacetamides and their use as glucokinase modulators
12/02/2004	US20040242681 6-O-(4-methoxyaniline)acetyl fumagillol for example; superior angiogenesis inhibitory effect with less toxicity, also a cancer metastasis inhibitor, and treats angiogenesis related disorders such as other various inflammatory diseases such as rheumatic disease, psoriasis, and diabetic retinopathy
12/02/2004	US20040242674 For example, (2'R,3'R)-13-[N-benzoyl-3-(2-furyl)-2-methyl-isoserinoyl]-baccatin III, (2'R,3'R)-13-[N-t-butoxycarbonyl-3-(2-furyl)-2-methyl-isoserinoyl]-baccatin III; antitumor activity against cancer cells of the breast, lung, ovary, colon, prostate, kidney, pancreas
12/02/2004	US20040242633 Compound used to lower cholesterol, reduce weight for dietetics, antidepressants and antidiabetic agents
12/02/2004	US20040242631 PI-3 kinase inhibitor prodrugs
12/02/2004	US20040242593 Cannabinoid derivatives, methods of making, and use thereof
12/02/2004	US20040242572 New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
12/02/2004	US20040242564 1,2,3,4-tetrahydroisoquinolines derivatives
12/02/2004	US20040242498 CXCR3 antagonists
12/02/2004	DE10308353A1 Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Diarylcycloalkylderivate, processes for their preparation and their use as medicaments
12/01/2004	EP1482019A1 Pyran derivatives
12/01/2004	EP1481975A1 Inhibitors of farnesyl protein transferase
12/01/2004	EP1480966A1 Compounds and methods of treating cell proliferative diseases
12/01/2004	EP1423385A4 Intermediates for preparing neuraminidase inhibitor conjugates
12/01/2004	CN1177821C Matrix metalloprotease inhibitors
11/2004
11/30/2004	US6825176 Synthesis and use of a probe that binds with specificity to the transactivation domain (tad) of human papillomavirus (hpv) e2 to form a complex, which is capable of being displaced by inhibitors of hpv
11/25/2004	WO2004101544A1 Benzyl sulfonamide derivatives as androgen receptor antagonists
11/25/2004	WO2004100998A2 Compositions and methods for non-invasive imaging of soluble beta-amyloid
11/25/2004	US20040236110 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
11/25/2004	US20040236098 Tocopheryl retinyl succinate, tocopheryl cholecalciferyl succinate or tocopheryl ascorbyl succinate; sustained releasing active agents or vitamin by hydrolyzing with esterase contained in the skin; dermatology, cosmetics
11/25/2004	US20040235897 3-[(1-benzyl-piperidin-4-yl)-(4-diethylcarbamoyl-phenyl)-amino]-benzamide used as opiod receptor agonists having improved pharmacokinetic, bioavailability, stability and/or lower toxicity; analgesisc; anxiolytic agents
11/25/2004	US20040235852 Benzofuran inhibitors of factor VIIa
11/25/2004	US20040235818 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/25/2004	US20040234587 Biomass; animal extracts; anticancer agents; learning enhancing
11/25/2004	CA2524434A1 Benzyl sulfonamide derivatives as androgen receptor antagonists
11/24/2004	EP1478639A1 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
11/24/2004	EP1478624A1 Chemical compounds
11/24/2004	EP1478437A1 Acc inhibitors
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004	CN1548428A Carboxylic acid derivatives having fused rings
11/24/2004	CN1176651C N-(3-benzofuryl) urea derivative
11/18/2004	WO2004099173A1 Multivalent inhibitors of serum amyloid p component
11/18/2004	US20040229909 Antiviral agent
11/18/2004	US20040229871 Nitrogen compounds such as 2-(5-(4-Fluoro-benzyloxy)-1,3-dioxo -1,3-dihydro-isoindol-2-yl)-acetamide, used for prophylaxis of Alzheimer's disease; amine oxidase inhibitors
11/18/2004	US20040229847 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/18/2004	DE10335782A1 Chromenonderivate Chromenonderivate
11/18/2004	CA2525302A1 Multivalent inhibitors of serum amyloid p component
11/18/2004	CA2524221A1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
11/17/2004	EP1476443A2 Process for preparing indolinone derivatives
11/17/2004	EP1286990B1 Stolonoxides
11/17/2004	EP0923569B1 Butyric acid matrix metalloproteinase inhibitors
11/11/2004	WO2004096208A1 Composition for oral administration containing alkylene dioxybenzene derivative
11/11/2004	WO2004085344A3 Production of oxy-michael adducts
11/11/2004	WO2004075853A9 Halogenated triptolide derivatives as immunomodulators and anticancer agents
11/11/2004	WO2004072044A3 Urea and thiourea derivatives
11/11/2004	US20040224993 Diphenylurea compounds
11/11/2004	US20040224960 Pharmaceutical compositions and methods for their use
11/11/2004	US20040224944 Pyrazole compounds useful as protein kinase inhibitors
11/11/2004	US20040223912 Compositions and methods for non-invasive imaging of soluble beta-amyloid
11/11/2004	US20040223909 Compositions and methods for non-invasive imaging of soluble beta-amyloid
11/11/2004	CA2523102A1 Substituted indoline and indole derivatives
11/10/2004	EP1474690A1 E2 displacement assay for identifying inhibitors of hpv
11/10/2004	EP1474399A1 Benzenesulfonamide derivatives as antipsychotic agents
11/10/2004	CN1544433A Extracting and separating method of novel langdu root essence B from stellera chamaejasme L and its uses
11/10/2004	CN1174974C Synthesis of ester ether compound with high acidolysis activity
11/09/2004	US6815465 Heterocyclic compounds inhibiting angiogenesis
11/09/2004	US6815458 Nervous system disorders
11/09/2004	US6815451 1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
11/04/2004	WO2004093856A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/04/2004	US20040220182 tyrosine kinase inhibitor; antitumor agents
11/04/2004	CA2522667A1 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/03/2004	EP1473293A1 Chromenon derivatives
11/03/2004	CN1542001A Small molecule inhibitors of rotamase enzyme activity
11/03/2004	CN1173964C Novel benzofuranone derivative and process for producing same
11/03/2004	CN1173947C 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
11/02/2004	CA2153903C Process for the preparation of 10-desacetoxybaccatin iii

1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 120